Validation of the Reagent Hormone AntiMullerian
Plus (Roche Diagnostics) for the Dosage of FSH Recombinant Delta (Ferring Pharmaceuticals) in Patients Submitted to
Techniques of Assisted Reproduction

Maria De Las Mercedes Calero Ruiz, Marta Rico Rodriguez, Olga Diz Mellado, Ana Isabel Mangano Armada, Maria Angeles BailÃƒÆ’Ã‚Â©n Garcia and Rafael Torrejon Cardoso

Ovarian stimulation is one of the fundamental pillars on which the treatment of in vitro fertilization is based The biopharmaceutical company Ferring has proposed the posology of recombinant FSH in an individualized manner according to the levels of anti-Mulleriana hormone in blood and body weight

免责声明: 此摘要通过人工智能工具翻译，尚未经过审核或验证

临床和实验室研究年鉴

索引于

分享此页面

抽象的

Validation of the Reagent Hormone AntiMullerian Plus (Roche Diagnostics) for the Dosage of FSH Recombinant Delta (Ferring Pharmaceuticals) in Patients Submitted to Techniques of Assisted Reproduction